InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Reports on Impact of New Product Experience at ADA Premier Conference
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, reported on new clinical research at the American Diabetes Association (“ADA”) Scientific Sessions, the premier diabetes conference. The company’s research evaluated the impact of the company's artificial intelligence (“AI”)-driven personalization engine on user engagement and clinical outcomes; the company’s study involved almost 10,000 users who were involved with a new product experience designed to…